Refractory Membranous Nephropathy
1 clinical trials · Condition
◉ Watch Refractory Membranous Nephropathy
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy (NCT07266181) | The First Affiliated Hospital of Air Force Medicial University | 2025-12-08 |
Track Refractory Membranous Nephropathy automatically
Every clearance here is in the API, with alerts when new ones post.